{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:33:37Z","timestamp":1772793217471,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":5213,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1538-7836.2008.03059.x","type":"journal-article","created":{"date-parts":[[2008,6,20]],"date-time":"2008-06-20T05:44:18Z","timestamp":1213940658000},"page":"1500-1506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?"],"prefix":"10.1016","volume":"6","author":[{"given":"A.M.","family":"GALLAGHER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"RIETBROCK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"PLUMB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.P.","family":"VAN STAA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/bmj.325.7371.1022","article-title":"ABC of antithrombotic therapy: antithrombotic therapy for atrial fibrillation","volume":"325","author":"Lip","year":"2002","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0015","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0020","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0025","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1538-7836.2006.01890.x","article-title":"Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review","volume":"4","author":"Szucs","year":"2006","journal-title":"J Thromb Haemostasis"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heart.86.3.284","article-title":"Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994\u20131998: analysis of data from the general practice research database","volume":"86","author":"Majeed","year":"2001","journal-title":"Heart"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0895-4356(01)00478-4","article-title":"Incidence of chronic atrial fibrillation in general practice and its treatment pattern","volume":"55","author":"Ruig\u00f3mez","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.thromres.2006.12.019","article-title":"Pre\u2010admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy","volume":"120","author":"Partington","year":"2007","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0050","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1161\/01.STR.0000173398.99163.9e","article-title":"Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care","volume":"36","author":"Simpson","year":"2005","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0055","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/01.STR.0000217263.55905.89","article-title":"Not all patients with atrial fibrillation\u2010associated ischemic stroke can be started on anticoagulant therapy","volume":"37","author":"Somerfield","year":"2006","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","article-title":"The underutilization of cardiac medications of proven benefit, 1990 to 2002","volume":"41","author":"Stafford","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0065","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.CIR.97.13.1231","article-title":"Recent national patterns of warfarin use in atrial fibrillation","volume":"97","author":"Stafford","year":"1998","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0070","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/archinte.165.13.1458","article-title":"Antithrombotic therapy practices in US hospitals in an era of practice guidelines","volume":"165","author":"Tapson","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0075","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1742-1241.2006.01241.x","article-title":"Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands \u2013 the EXAMINE\u2010AF study. A questionnaire survey","volume":"61","author":"Dinh","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pds.1329","article-title":"Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France","volume":"16","author":"Leizorovicz","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0090","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/eurheartj\/ehl146","article-title":"Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort\u2010study on Atrial Fibrillation (SCAF\u2010study)","volume":"27","author":"Friberg","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/archinte.167.3.246","article-title":"Newly detected atrial fibrillation and compliance with antithrombotic guidelines","volume":"167","author":"Glazer","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0100","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.STR.32.2.392","article-title":"Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital\u2010based registry (The European Community Stroke Project)","volume":"32","author":"Lamassa","year":"2001","journal-title":"Stroke"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0105","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/eurheartj\/ehi505","article-title":"Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation","volume":"26","author":"Nieuwlaat","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0110","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/hrt.2005.069492","article-title":"Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care","volume":"92","author":"DeWilde","year":"2006","journal-title":"Heart"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK General Practice Research Database","volume":"350","author":"Walley","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ahj.2008.03.010","article-title":"Chronic atrial fibrillation: incidence, prevalence and prediction of stroke using the CHADS2 risk stratification scheme","volume":"156","author":"Rietbrock","year":"2008","journal-title":"Am Heart J"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0125","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0149-2918(03)80167-4","article-title":"Factors influencing physicians\u2019 reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross\u2010sectional survey","volume":"25","author":"Gross","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0130","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.130.5.1296","article-title":"Bleeding risk stratification models in deciding on anticoagulation in patients with atrial fibrillation","volume":"130","author":"Kakar","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic overview of warfarin and its drug and food interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0140","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.166.9.1009","article-title":"Reducing warfarin medication interactions: an interrupted time series evaluation","volume":"166","author":"Feldstein","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03059.x_bb0145","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1378\/chest.129.5.1155","article-title":"Effect of study setting on anticoagulation control: a systematic review and metaregression","volume":"129","author":"Van Walraven","year":"2006","journal-title":"Chest"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03059.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622132459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622132459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03059.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:46:05Z","timestamp":1761533165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622132459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1538783622132459"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03059.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03059.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}